Trial Profile
Assessment of the Effect of Food on ABT-143 Bioavailability.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2012
Price :
$35
*
At a glance
- Drugs Rosuvastatin/choline fenofibrate (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Abbott Laboratories
- 12 Feb 2009 Actual patient numbers (115) added as reported by ClinicalTrials.gov.
- 12 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2008 New trial record.